Ajooni Biotech Limited

NSEI:AJOONI 株式レポート

時価総額：₹1.4b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Ajooni Biotech マネジメント

マネジメント 基準チェック /44

現在、CEO に関する十分な情報がありません。

主要情報

Gursimran Singh

最高経営責任者

₹1.2m

報酬総額

CEO給与比率100.0%
CEO在任期間4.1yrs
CEOの所有権n/a
経営陣の平均在職期間4.6yrs
取締役会の平均在任期間7.1yrs

経営陣の近況

Recent updates

Ajooni Biotech Limited (NSE:AJOONI) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Sep 04
Ajooni Biotech Limited (NSE:AJOONI) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Ajooni Biotech Limited's (NSE:AJOONI) 27% Share Price Surge Not Quite Adding Up

Jul 12
Ajooni Biotech Limited's (NSE:AJOONI) 27% Share Price Surge Not Quite Adding Up

Market Cool On Ajooni Biotech Limited's (NSE:AJOONI) Earnings Pushing Shares 25% Lower

Mar 20
Market Cool On Ajooni Biotech Limited's (NSE:AJOONI) Earnings Pushing Shares 25% Lower

We Ran A Stock Scan For Earnings Growth And Ajooni Biotech (NSE:AJOONI) Passed With Ease

Nov 10
We Ran A Stock Scan For Earnings Growth And Ajooni Biotech (NSE:AJOONI) Passed With Ease

We Ran A Stock Scan For Earnings Growth And Ajooni Biotech (NSE:AJOONI) Passed With Ease

Jul 13
We Ran A Stock Scan For Earnings Growth And Ajooni Biotech (NSE:AJOONI) Passed With Ease

If You Like EPS Growth Then Check Out Ajooni Biotech (NSE:AJOONI) Before It's Too Late

Feb 16
If You Like EPS Growth Then Check Out Ajooni Biotech (NSE:AJOONI) Before It's Too Late

Should Weakness in Ajooni Biotech Limited's (NSE:AJOONI) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Feb 14
Should Weakness in Ajooni Biotech Limited's (NSE:AJOONI) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Did Ajooni Biotech Limited (NSE:AJOONI) Insiders Buy Up More Shares?

Dec 24
Did Ajooni Biotech Limited (NSE:AJOONI) Insiders Buy Up More Shares?

CEO報酬分析

Ajooni Biotech の収益と比較して、Gursimran Singh の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2024n/an/a

₹22m

Mar 31 2024₹1m₹1m

₹22m

Dec 31 2023n/an/a

₹18m

Sep 30 2023n/an/a

₹15m

Jun 30 2023n/an/a

₹12m

Mar 31 2023₹1m₹1m

₹11m

Dec 31 2022n/an/a

₹5m

Sep 30 2022n/an/a

₹9m

Jun 30 2022n/an/a

₹11m

Mar 31 2022₹2m₹2m

₹10m

Dec 31 2021n/an/a

₹11m

Sep 30 2021n/an/a

₹7m

Jun 30 2021n/an/a

₹4m

Mar 31 2021₹540k₹540k

₹4m

報酬と市場: Gursimranの 総報酬 ($USD 14.36K ) は、 Indian市場 ($USD 39.08K ) の同様の規模の企業の平均を下回っています。

報酬と収益: Gursimranの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Gursimran Singh (36 yo)

4.1yrs

在職期間

₹1,200,000

報酬

Mr. Gursimran Singh had been the Chief Financial Officer of Prism Medico and Pharmacy Limited December 4, 2017 until May 16, 2023 and served as its Executive Director from April 01, 2017 to October 5, 2019...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Jasjot Singh
Chairman7.1yrs₹3.00m13.96%
₹ 199.1m
Gursimran Singh
CEO & Whole Time Directorno data₹1.20mデータなし
Partek Singh
Executive & Non-Independent Director7.3yrs₹300.00kデータなし
Swati Vijan
Company Secretary & Compliance Officer4.6yrs₹571.00kデータなし

4.6yrs

平均在職期間

36yo

平均年齢

経験豊富な経営陣: AJOONIの経営陣は 経験豊富 であると考えられます ( 4.3年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Jasjot Singh
Chairman7.1yrs₹3.00m13.96%
₹ 199.1m
Gursimran Singh
CEO & Whole Time Director4.1yrs₹1.20mデータなし
Partek Singh
Executive & Non-Independent Director7.3yrs₹300.00kデータなし
Simmi Chhabra
Independent Non-Executive Woman Director7.1yrs₹30.00k0.037%
₹ 524.7k
Imteshwar Bhatia
Independent Non-Executive Director7.1yrs₹30.00kデータなし
Ramandeep Singh
Independent Non-Executive Director7.1yrs₹30.00kデータなし

7.1yrs

平均在職期間

36.5yo

平均年齢

経験豊富なボード: AJOONIの 取締役会 は 経験豊富 であると考えられます ( 6.8年の平均在任期間)。